| Enhancer ID: | E_02_0511 |
| Species: | human |
| Position : | chr6:16296402-16298402 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Spinocerebellar ataxia type 1 (sca1), amyotrophic lateral sclerosis (als), huntington's disease (hd), parkinson's disease, multiple system atrophy (msa) |
| Pubmed ID: | 30043530 |
| Enhancer experiment: | Rotarod analysis, quantitative analysis of immunofluorescent staining, Western blot, RT qPCR, statistical analysis |
| Enhancer experiment description: | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
| Target gene : | ATXN1 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
| TF name : | -- |
| TF experiment: | Rotarod analysis,Quantitative Analysis of immunofluorescent staining,Western blot,RT-qPCR,???? |
| TF experiment description: | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
| Enhancer function : | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|